Hers vs Yucca Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent researchHow we rank →

Yucca Health beats Hers overall, scoring 7.7/10 vs 7.3/10. Yucca Health is more affordable at $146/mo vs $199/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Yucca Health for people who'll commit to a 6-month plan for $146/mo, want nam.

A side-by-side comparison of Hers and Yucca Health covering pricing, scores, medication types, insurance, and more to help you decide.

Hers

#35 of 49
7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers
Higher Rated

Yucca Health

#19 of 49
7.7/10

Online weight-loss program by Yucca Health, Inc. (Beverly Hills, CA). Two named board-certified doctors — Dr. Michael Wasef MD and Dr. Andrew Sakla DO — handle prescribing. 20,000+ patients, 4.6 stars across 1,065 verified Trustpilot reviews. Starts at $146/mo for compounded semaglutide (custom-made version, not the FDA-approved brand) on the 6-month plan. Buy-now-pay-later via Klarna, Affirm, or Afterpay spreads the upfront commitment.

Visit Yucca Health
FeatureHersYucca Health
Our Score7.3/107.7/10
Starting Price$199/mo$146/mo
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForWomen who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brandPeople who'll commit to a 6-month plan for $146/mo, want named doctors on record, and like buy-now-pay-later flexibility (Klarna/Affirm/Afterpay)
Ranking#35#19

Pros & Cons Compared

Hers

Pros

  • +2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
  • +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
  • +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
  • +Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

  • Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
  • Generic support experience — large patient volume means less personalized attention
  • Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
  • Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Yucca Health

Pros

  • +Two named board-certified doctors (Dr. Michael Wasef MD and Dr. Andrew Sakla DO) — most compounded GLP-1 providers don't publicly name their prescribers.
  • +4.6 stars across 1,065 verified Trustpilot reviews — 84% give 5 stars. Top complimented theme: customer service.
  • +Cheap if you commit: $146/mo for compounded semaglutide on the 6-month plan.
  • +Buy-now-pay-later through Klarna, Affirm, and Afterpay — unusual flexibility in this category, useful for spreading the 6-month upfront cost.
  • +24-hour async approval — no live video visit required. Faster onboarding than competitors that need a scheduled call.
  • +UPS 2-Day Air shipping included. Onboarding call from a real human (multiple Trustpilot reviewers name 'Hazel' and 'Johann' from the team).
  • +Replies to 100% of negative Trustpilot reviews, usually within 48 hours.

Cons

  • Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro.
  • The $146/mo price requires a 6-month upfront commitment. Month-to-month is meaningfully more expensive.
  • No live tele-visit option — only async review. Faster, but less depth if you have a complex health history.
  • Pharmacy partner not named publicly. Yucca says 'U.S. licensed pharmacies' but doesn't disclose which one.
  • Founders and detailed company history not on the site.
  • Refund policy is mentioned but not detailed publicly — verify the cancellation terms before paying for the 6-month plan.

Our Verdict

Yucca Health edges out Hers with a score of 7.7/10 vs 7.3/10. If budget is your priority, Yucca Health starts at $146/mo compared to Hers's $199/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Yucca Health if you want: people who'll commit to a 6-month plan for $146/mo, want named doctors on record, and like buy-now-pay-later flexibility (klarna/affirm/afterpay).

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor Yucca Health feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Hers

Starting at $199/mo

Visit Hers

Try Yucca Health

Starting at $146/mo

Visit Yucca Health

Related comparisons

Other matchups readers comparing Hers or Yucca Health tend to look at next.

Top Picks

Four programs our readers click through most.

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Sesame Care

7.9/10
$99/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.